| EP2930176 - HYDANTOIN DERIVATIVE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.12.2018 Database last updated on 30.03.2026 | |
| Former | The patent has been granted Status updated on 05.01.2018 | ||
| Former | Grant of patent is intended Status updated on 10.07.2017 | ||
| Former | Request for examination was made Status updated on 27.06.2017 | ||
| Former | Grant of patent is intended Status updated on 01.02.2017 | Most recent event Tooltip | 14.12.2018 | No opposition filed within time limit | published on 16.01.2019 [2019/03] | Applicant(s) | For all designated states Chugai Seiyaku Kabushiki Kaisha 5-1, Ukima 5-chome Kita-ku Tokyo 115-8543 / JP | [2015/42] | Inventor(s) | 01 /
NISHIMURA, Yoshikazu c/o CHUGAI SEIYAKU KABUSHIKI KAISHA 135 Komakado 1-chome Gotemba-shi Shizuoka 412-8513 / JP | 02 /
ESAKI, Toru c/o CHUGAI SEIYAKU KABUSHIKI KAISHA 135 Komakado 1-chome Gotemba-shi Shizuoka 412-8513 / JP | 03 /
TAMURA, Tatsuya c/o CHUGAI SEIYAKU KABUSHIKI KAISHA 135 Komakado 1-chome Gotemba-shi Shizuoka 412-8513 / JP | [2015/42] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2015/42] | Application number, filing date | 13862318.6 | 10.12.2013 | [2015/42] | WO2013JP83022 | Priority number, date | JP20120269178 | 10.12.2012 Original published format: JP 2012269178 | [2015/42] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014092061 | Date: | 19.06.2014 | Language: | JA | [2014/25] | Type: | A1 Application with search report | No.: | EP2930176 | Date: | 14.10.2015 | Language: | EN | [2015/42] | Type: | B1 Patent specification | No.: | EP2930176 | Date: | 07.02.2018 | Language: | EN | [2018/06] | Search report(s) | International search report - published on: | JP | 19.06.2014 | (Supplementary) European search report - dispatched on: | EP | 02.05.2016 | Classification | IPC: | C07D471/10, A61K31/438, A61P3/14, A61P5/18, A61P43/00, C07D519/00 | [2015/42] | CPC: |
C07D471/10 (EP,CN,RU,US);
A61K31/438 (RU);
A61P19/00 (EP);
A61P3/00 (EP);
A61P3/14 (EP,RU);
A61P43/00 (EP,RU);
A61P5/00 (EP);
A61P5/18 (EP,RU);
C07D491/10 (RU);
C07D519/00 (EP,CN,RU,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/42] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | HYDANTOINDERIVATE | [2015/42] | English: | HYDANTOIN DERIVATIVE | [2015/42] | French: | DÉRIVÉ D'HYDANTOÏNE | [2015/42] | Entry into regional phase | 02.07.2015 | Translation filed | 02.07.2015 | National basic fee paid | 02.07.2015 | Search fee paid | 02.07.2015 | Designation fee(s) paid | 02.07.2015 | Examination fee paid | Examination procedure | 02.07.2015 | Amendment by applicant (claims and/or description) | 02.07.2015 | Examination requested [2015/42] | 02.02.2017 | Communication of intention to grant the patent | 12.06.2017 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 12.06.2017 | Fee for grant paid | 12.06.2017 | Fee for publishing/printing paid | 11.07.2017 | Communication of intention to grant the patent | 08.11.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 02.02.2017 | Opposition(s) | 08.11.2018 | No opposition filed within time limit [2019/03] | Fees paid | Renewal fee | 22.12.2015 | Renewal fee patent year 03 | 23.12.2016 | Renewal fee patent year 04 | 21.12.2017 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 07.02.2018 | EE | 07.02.2018 | SM | 07.02.2018 | [2018/52] |
| Former [2018/50] | CY | 07.02.2018 | |
| EE | 07.02.2018 | ||
| Former [2018/37] | CY | 07.02.2018 | Documents cited: | Search | No further relevant documents disclosed | by applicant | WO2010126030 | KRONENBERG, H.M. ET AL.: "Handbook of Experimental Pharmacology", 1993, SPRINGER-VERLAG, pages: 185 - 201 | TASHJIAN; GAGEL, J. BONE MINER. RES., vol. 21, 2006, pages 354 - 365 | REJNMARK ET AL., OSTEOPOROSIS INT., 27 November 2012 (2012-11-27) | WINER KK ET AL., J. CLIN. ENDOCRINOL. METAB., vol. 88, no. 9, 2003, pages 4214 - 4220 | J. BONE, MINER. RES., vol. 14, 1999, pages 11 - 20 | T. KRONBACH ET AL.: "Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4", MOL. PHARMACOL, vol. 36, no. 1, 1989, pages 89 - 96 | CHEMISTRY-A EUROPEAN JOURNAL, vol. 8, no. 2, 2002, pages 439 - 450 | TAKASU ET AL., J. BONE. MINER. RES., vol. 14, 1999, pages 11 - 20 |